These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38777176)

  • 41. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending.
    Builders PF; Bonaventure AM; Tiwalade A; Okpako LC; Attama AA
    Int J Pharm; 2010 Mar; 388(1-2):159-67. PubMed ID: 20060448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Imaging Toolkit for Physical Characterization of Long-Acting Pharmaceutical Implants.
    Skomski D; Liu Z; Su Y; John CT; Doty A; Forster SP; Teller R; Barrett SE; Xu W
    J Pharm Sci; 2020 Sep; 109(9):2798-2811. PubMed ID: 32534030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.
    Shukla D; Chakraborty S; Singh S; Mishra B
    Expert Opin Drug Deliv; 2011 Feb; 8(2):207-24. PubMed ID: 21210754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examination of factors that delay the elution of acetaminophen from over-the-counter drugs.
    Ota M; Fukami T; Arakawa M; Hayashi H; Suzuki T; Iwata M; Tomono K; Hidaka S
    Pharmazie; 2012 Dec; 67(12):1018-25. PubMed ID: 23346767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SEM/EDX and confocal Raman microscopy as complementary tools for the characterization of pharmaceutical tablets.
    Scoutaris N; Vithani K; Slipper I; Chowdhry B; Douroumis D
    Int J Pharm; 2014 Aug; 470(1-2):88-98. PubMed ID: 24836664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review on taste masked multiparticulate dosage forms for paediatric.
    Al-Japairai K; Hamed Almurisi S; Almonem Doolaanea A; Mahmood S; Alheibshy F; Alobaida A; Abdul-Halim N; Chatterjee B
    Int J Pharm; 2023 Feb; 632():122571. PubMed ID: 36587776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.
    Fang WJ; Qi W; Kinzell J; Prestrelski S; Carpenter JF
    Pharm Res; 2012 Dec; 29(12):3278-91. PubMed ID: 22766900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphological evaluation of low-dose midazolam granules by laser Raman microscopy.
    Imoto J; Uchida S; Kashiwagura Y; Tanaka S; Namiki N
    Int J Pharm; 2020 Nov; 590():119940. PubMed ID: 33011249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Going green: Development of a sustainable lipid-based enteric coating formulation for low-dose aspirin multiparticulate systems.
    Schertel S; Corzo C; Leitner L; Karrer J; Engel D; Teichmann Y; Zimmer A; Salar-Behzadi S
    Int J Pharm; 2022 Feb; 614():121453. PubMed ID: 35021045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components.
    Muthudoss P; Kumar S; Ann EYC; Young KJ; Chi RLR; Allada R; Jayagopal B; Dubala A; Babla IB; Das S; Mhetre S; Saraf I; Paudel A
    J Pharm Biomed Anal; 2022 Feb; 210():114581. PubMed ID: 35026592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suitability of a minipig model in assessing clinical bioperformance of matrix and multiparticulate extended-release formulations for a BCS class III Drug development candidate.
    Kesisoglou F; Xie IH; Manser K; Wu Y; Hardy I; Fitzpatrick S
    J Pharm Sci; 2014 Feb; 103(2):636-42. PubMed ID: 24382706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
    Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
    J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM.
    Falsafi SR; Rostamabadi H; Assadpour E; Jafari SM
    Adv Colloid Interface Sci; 2020 Jun; 280():102166. PubMed ID: 32387755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities.
    Whitaker N; Xiong J; Pace SE; Kumar V; Middaugh CR; Joshi SB; Volkin DB
    J Pharm Sci; 2017 Nov; 106(11):3230-3241. PubMed ID: 28668340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate.
    Theil F; Milsmann J; Kyeremateng SO; Anantharaman S; Rosenberg J; van Lishaut H
    Mol Pharm; 2017 Dec; 14(12):4636-4647. PubMed ID: 29111751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.